论文信息 - Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK). - 字舞流文

Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK).

C. Lepage | R. Guimbaud | V. Boige | J. Selves | J. Taieb | P. Michel | F. Di Fioré | J. Bachet | K. Le Malicot | T. André | D. Tougeron | L. Dahan | E. Maillard | T. Aparicio | S. Manfredi